Prestige Consumer Healthcare Inc. buy Oppenheimer Holdings Inc.
Start price
13.02.25
/
50%
€80.50
Target price
13.02.26
€89.17
Performance (%)
-31.06%
End price
14.02.26
€55.50
Summary
This prediction ended on 14.02.26 with a price of €55.50. Massive losses of -31.06% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has a follow-up prediction for Prestige Consumer Healthcare Inc. where he still thinks Prestige Consumer Healthcare Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -4.717% | -4.717% | -35.669% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $87.00 to $93.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€53.00
21.10.25
21.10.25
€61.83
21.10.26
21.10.26
-7.17%
08:50
08:50
